|
1
|
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
|
Nature
|
2011
|
3.53
|
|
2
|
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
|
PLoS Genet
|
2013
|
2.39
|
|
3
|
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
|
Cancer Res
|
2010
|
1.90
|
|
4
|
Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants.
|
Hum Mutat
|
2012
|
1.77
|
|
5
|
Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers.
|
EMBO Mol Med
|
2011
|
1.68
|
|
6
|
External quality assessment for KRAS testing is needed: setup of a European program and report of the first joined regional quality assessment rounds.
|
Oncologist
|
2011
|
1.59
|
|
7
|
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.
|
Hum Mol Genet
|
2011
|
1.51
|
|
8
|
Implementation of formalin-fixed, paraffin-embedded cell line pellets as high-quality process controls in quality assessment programs for KRAS mutation analysis.
|
J Mol Diagn
|
2012
|
1.44
|
|
9
|
A guide for functional analysis of BRCA1 variants of uncertain significance.
|
Hum Mutat
|
2012
|
1.34
|
|
10
|
Guideline on the requirements of external quality assessment programs in molecular pathology.
|
Virchows Arch
|
2012
|
1.24
|
|
11
|
Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.
|
Am J Gastroenterol
|
2008
|
1.20
|
|
12
|
Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases.
|
Nucleic Acids Res
|
2011
|
1.11
|
|
13
|
EMMA, a cost- and time-effective diagnostic method for simultaneous detection of point mutations and large-scale genomic rearrangements: application to BRCA1 and BRCA2 in 1,525 patients.
|
Hum Mutat
|
2011
|
1.08
|
|
14
|
CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study.
|
J Med Genet
|
2013
|
1.05
|
|
15
|
PIK3R1 underexpression is an independent prognostic marker in breast cancer.
|
BMC Cancer
|
2013
|
0.99
|
|
16
|
Germline APC mutation spectrum derived from 863 genomic variations identified through a 15-year medical genetics service to French patients with FAP.
|
J Med Genet
|
2010
|
0.98
|
|
17
|
Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy.
|
Mol Cancer
|
2011
|
0.95
|
|
18
|
Multiple sequence variants of BRCA2 exon 7 alter splicing regulation.
|
J Med Genet
|
2012
|
0.94
|
|
19
|
Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers.
|
J Cancer Epidemiol
|
2009
|
0.91
|
|
20
|
International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation.
|
Breast Cancer Res Treat
|
2010
|
0.91
|
|
21
|
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.
|
Breast Cancer Res
|
2014
|
0.89
|
|
22
|
Role of microsatellite instability in the management of colorectal cancers.
|
Dig Liver Dis
|
2012
|
0.87
|
|
23
|
Performance and cost efficiency of KRAS mutation testing for metastatic colorectal cancer in routine diagnosis: the MOKAECM study, a nationwide experience.
|
PLoS One
|
2013
|
0.86
|
|
24
|
Quantification of PKC family genes in sporadic breast cancer by qRT-PCR: evidence that PKCι/λ overexpression is an independent prognostic factor.
|
Int J Cancer
|
2012
|
0.85
|
|
25
|
A diagnostic genetic test for the physical mapping of germline rearrangements in the susceptibility breast cancer genes BRCA1 and BRCA2.
|
Hum Mutat
|
2012
|
0.81
|
|
26
|
Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases.
|
Genes Chromosomes Cancer
|
2015
|
0.79
|
|
27
|
A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysis.
|
Genet Test Mol Biomarkers
|
2010
|
0.78
|
|
28
|
An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition.
|
BMC Med Genet
|
2011
|
0.77
|
|
29
|
A missense variant within BRCA1 exon 23 causing exon skipping.
|
Cancer Genet Cytogenet
|
2010
|
0.77
|
|
30
|
Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
|
Nature
|
2015
|
0.75
|
|
31
|
[Hereditary forms of ovarian cancer].
|
Bull Cancer
|
2012
|
0.75
|
|
32
|
[Evaluation of residual immune response against human pox virus before and after revaccination in healthy volunteers].
|
Bull Acad Natl Med
|
2007
|
0.75
|
|
33
|
Primary jejunal adenocarcinoma incidentally diagnosed on positron emission tomography/computed tomography in a patient with metastatic colorectal cancer: suspicion of Lynch syndrome and effect on therapeutic management.
|
J Clin Oncol
|
2013
|
0.75
|